Vaxfab Enterprises Ltd — Important, 13-04-2026: Company Update

Vaxfab Enterprises' Board has approved its standalone and consolidated unaudited financial results for the quarter ended 31st December, 2025. However, auditors issued a limited review report with significant concerns, indicating they were unable to form an opinion on the standalone results due to insufficient audit evidence. Issues include unsecured loans without agreements, unsupported trade receivables and payables, lack of MSMED Act compliance details, inadequate documentation for goods movement, and no provision for gratuity or impairment assessment. These deficiencies raise material questions about the reliability of the financial statements for the period.